- Home
- KEN vs OCUL Comparison
KEN vs OCUL Comparison
Compare KEN & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KEN | OCUL |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | KEN | OCUL |
|---|---|---|
| Price | $60.99 | $12.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $22.33 |
| AVG Volume (30 Days) | 10.6K | ★ 2.6M |
| Earning Date | 12-03-2025 | 11-04-2025 |
| Dividend Yield | ★ 7.82% | N/A |
| EPS Growth | ★ 177.70 | N/A |
| EPS | ★ 8.96 | N/A |
| Revenue | ★ $803,304,000.00 | $55,783,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.88 |
| P/E Ratio | $6.68 | ★ N/A |
| Revenue Growth | ★ 8.15 | N/A |
| 52 Week Low | $27.10 | $5.79 |
| 52 Week High | $62.88 | $13.85 |
Technical Indicators
Market Signals| Indicator | KEN | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 69.04 | 61.29 |
| Support Level | $60.63 | $11.15 |
| Resistance Level | $62.88 | $13.00 |
| Average True Range (ATR) | 1.18 | 0.64 |
| MACD | 0.20 | 0.07 |
| Stochastic Oscillator | 81.53 | 82.29 |
Price Performance
Historical ComparisonAbout KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.